ArticleJournal of enzyme inhibition and medicinal chemistry2021

Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells.

Mohammad M Al-Sanea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.